SGLT2 Inhibitors
Sort by:
The Texas Heart Institute
Cardiometabolic Health: Actionable Prevention Strategies and New Care Models
FEATURING
David Aguilar
- 396 views
- September 7, 2023
- 4
The Texas Heart Institute
Heart Failure Guidelines
FEATURING
Biykem Bozkurt
- 961 views
- September 7, 2023
- 7
Practical Ways to Achieve Targets in Diabetes Care
Cost Effectiveness of Newer Treatment Options for Type 2 Diabetes
FEATURING
Sandip Garg
- 552 views
- August 23, 2023
- 3
Canadian Collaborative Research Network
Chronic Kidney Disease: New Treatments to Improve Outcomes
FEATURING
Louise Moist
- 1,527 views
- July 26, 2023
- 10
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
FEATURING
Rajeev C. Mohan
- 727 views
- June 13, 2023
- 10
Scripps Health
Heart Failure: Guideline Based and Novel Therapies
FEATURING
Rola Khedraki
- 1,102 views
- June 13, 2023
- 11
Scripps Health
Reading Between the Guidelines for Management of Heart Failure
FEATURING
Lynne Warner Stevenson
- 1,425 views
- June 13, 2023
- 9
Scripps Health
Diabetes and Cardiovascular Disease: Medications and Interventions to Improve Outcomes
FEATURING
Athena Philis-Tsimikas
- 226 views
- June 13, 2023
- 2
ARCH Advanced Revascularization Symposium
Advanced Heart Failure Therapies: Update
FEATURING
Douglas Horstmanshof
- 202 views
- May 12, 2023
Scripps Health
Updates in Hospital Medicine
FEATURING
Karla Williams,
Keandrea Titer
- 363 views
- April 26, 2023
- 2
ACC 2023 Conference Coverage
ACC 2023: Beyond the Guidelines - Emerging Pharmacologic Therapies for the Heart Failure Treatment
FEATURING
Freny Mody
- 1,868 views
- April 25, 2023
- 12
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
FEATURING
Anastasia Armbruster
- 17,429 views
- March 31, 2023
- 95
ACC 2023 Conference Coverage
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
FEATURING
Barry Borlaug
- 1,317 views
- March 15, 2023
- 9
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
FEATURING
Stephanie Coulter,
Darren K. Mcguire
- 56 views
- March 10, 2023
- 1
Canadian Collaborative Research Network
New Management Options for Chronic Kidney Disease
FEATURING
Grace Chua
- 1,728 views
- February 22, 2023
- 7
Houston Methodist DeBakey Heart and Vascular Center
Impact and Management of Cardiometabolic Disease in Heart Failure
FEATURING
Robert Mentz
- 277 views
- February 10, 2023
- 1
St. Louis Shock & Heart Failure Symposium 2022
Heart Failure Therapy: Focus on Guidelines
FEATURING
Justin Vader
- 1,130 views
- January 9, 2023
- 9
AHA 2022 Conference Coverage
AHA 2022: GDMT for HFpEF - What Do We and Don't We Know?
FEATURING
Marat Fudim
- 1,412 views
- November 30, 2022
- 11
American College of Cardiology
AHA 2022: ECMO-CS, RESPECT-EPA, ISCHEMIA-EXTENDed and EMPA-KIDNEY Trials
- 638 views
- November 24, 2022
Top Ten Topics in Clinical Cardiology 2022
Time to Erase Boundary Between HFrEF & HFpEF? At Least Therapeutics Suggest So!
FEATURING
Biykem Bozkurt
- 492 views
- November 21, 2022
- 3
Top Ten Topics in Clinical Cardiology 2022
Panel Discussion: Genetic Testing and Lipid Management
- 31 views
- November 21, 2022